First human test for new pneumonia shot
NCT ID NCT07059182
Summary
This early-stage study tested the safety of a new experimental vaccine designed to prevent serious pneumococcal infections, including pneumonia and severe ear infections. Thirty healthy adults received either the vaccine or a placebo injection and were monitored for side effects for 30 days. The main goal was to see if the vaccine was safe and well-tolerated before further testing.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rochester Clinical Research
Rochester, New York, 14609, United States
Conditions
Explore the condition pages connected to this study.